Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Carole Maupain is active.

Publication


Featured researches published by Carole Maupain.


Resuscitation | 2017

Thrombus composition in sudden cardiac death from acute myocardial infarction

Johanne Silvain; Jean-Philippe Collet; Paul Guedeney; Olivier Varenne; Chandrasekaran Nagaswami; Carole Maupain; Jean-Philippe Empana; Chantal M. Boulanger; Muriel Tafflet; Stéphane Manzo-Silberman; Mathieu Kerneis; Delphine Brugier; Nicolas Vignolles; John W. Weisel; Xavier Jouven; Gilles Montalescot; Christian Spaulding

BACKGROUND AND AIM It was hypothesized that the pattern of coronary occlusion (thrombus composition) might contribute to the onset of ventricular arrhythmia and sudden cardiac death (SCD) in myocardial infarction (MI). METHODS The TIDE (Thrombus and Inflammation in sudden DEath) study included patients with angiographically-proven acute coronary occlusion as the cause of a ST elevation MI (STEMI) complicated by Sudden Cardiac Death (SCD group) or not (STEMI group). Thrombi were obtained by thrombo-aspiration before primary percutaneous coronary stenting and analyzed with a quantitative method using scanning electron microscopy. We compared the composition of the thrombi responsible for the coronary occlusion between the two groups and evaluated factors influencing its composition. RESULTS We included 121 patients and found that thrombus composition was not different between the SCD group (n=23) and the STEMI group (n=98) regarding content of fibrin fibers (60.3±18.4% vs. 62.4±18.4% respectively, p=0.68), platelets (16.3±19.2% vs. 15.616.7±%, p=0.76), erythrocytes (14.6±12.5% vs. 13±12.1%, p=0.73) and leukocytes (0.6±0.9% vs. 0.8±1.5%, p=0.93). Thrombus composition did not differ between patients receiving upstream-use of glycoprotein IIb/IIIa platelet receptor inhibitors (GPI) and patients free of GPI. The only factor found to influence thrombus composition was the ischemic time from symptom onset to primary PCI, with a decreased content in fibrin fibers (57.8±18.5% vs. 71.9±10.1%, p=0.0008) and a higher platelet content (19.2±19.1% vs. 7.9±5.7% p=0.014) in early presenters (<3h of ischemic time) vs. late presenters (>6h of ischemic time). CONCLUSION Composition of intracoronary thrombi in STEMI patients does not differ between those presenting with and without SCD. Time from symptom onset to coronary reperfusion seems to be the strongest factor influencing thrombus composition in MI.


Journal of Heart and Lung Transplantation | 2017

Catheter ablation of organized atrial arrhythmias in orthotopic heart transplantation

Yamina Mouhoub; Mikael Laredo; Shaida Varnous; Pascal Leprince; Xavier Waintraub; Estelle Gandjbakhch; Jean-Louis Hébert; Robert Frank; Carole Maupain; Alain Pavie; Françoise Hidden-Lucet; Guillaume Duthoit

BACKGROUND Organized atrial arrhythmias (OAAs) are common after orthotopic heart transplantation (OHT). Some controversies remain about their clinical presentation, relationship with atrial anastomosis and electrophysiologic features. The objectives of this retrospective study were to determine the mechanisms of OAAs after OHT and describe the outcomes of radiofrequency catheter ablation (RFCA). METHODS Thirty consecutive transplanted patients (mean age 48 ± 17 years, 86.6% male) underwent 3-dimensional electroanatomic mapping and RFCA of their OAA from 2004 to 2012 at our center. RESULTS Twenty-two patients had biatrial anastomosis and 8 had bicaval anastomosis. Macro-reentry was the arrhythmia mechanism for 96% of patients. The electrophysiologic diagnoses were: cavotricuspid isthmus (CTI)-dependent atrial flutter (AFL) in 93% of patients (n = 28); perimitral AFL in 3% (n = 1); and focal atrial tachycardia (FAT) in 3% (n = 1). In 5 patients with biatrial anastomosis, a right FAT was inducible. Primary RFCA success was obtained in 93% of patients. Mean follow-up time was 39 ± 26.8 months. Electrical repermeation between recipient and donor atria, present in 20% of patients (n = 6), did not account for any of the OAAs observed. Survival without OAA relapse at 12, 24 and 60 months was 93%, 89% and 79%, respectively. CONCLUSIONS CTI-dependent AFL accounted for most instances of OAA after OHT, regardless of anastomosis type. Time from transplantation to OAA was shorter with bicaval than with biatrial anastomosis. RFCA was safe and provided good long-term results.


Archives of Cardiovascular Diseases | 2016

Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry.

Estelle Gandjbakhch; Marion Rovani; Shaida Varnous; Carole Maupain; Thomas Chastre; Xavier Waintraub; Françoise Pousset; Guillaume Lebreton; Guillaume Duthoit; Nicolas Badenco; Caroline Himbert; Pascal Leprince; Françoise Hidden-Lucet

BACKGROUND Implantable cardioverter-defibrillators (ICDs) are recommended in patients with low ejection fraction. However, the survival benefit of ICDs in patients with end-stage heart failure listed for heart transplantation is unclear. AIM To evaluate the ICD benefit on mortality in this population. METHODS Three hundred and eighty consecutive patients listed for heart transplantation between 2005 and 2009 in one tertiary heart transplant centre were enrolled in a retrospective registry; 122 patients received an ICD before or within 3 months after being listed for heart transplantation (ICD group). Predictors of death on the waiting list were assessed by Cox regression. RESULTS Overall, 15.6% of patients died while awaiting heart transplantation. Non-ICD patients presented more often haemodynamic compromise requiring mechanical circulatory support (29.1% vs. 9.8%; P<0.001), and were more likely to die while on the waiting list (19.0% vs. 8.3%; log-rank P=0.001). However, in the multivariable model, ICD did not remain an independent predictor of death. Need for mechanical circulatory support (P<0.001), low ejection fraction (P=0.001) and registration on the regular list (P=0.008) were the only independent predictors of death. Death was mainly caused by haemodynamic compromise (76.3% of deaths), which occurred more frequently in the non-ICD group (14.7% vs. 5.8%; log-rank P=0.002). Unknown/arrhythmic deaths did not differ significantly between the two groups (3.9% vs. 1.7%; log-rank P=0.21). ICD-related complications occurred in 21.4% of patients, mainly as a result of postoperative worsening of heart failure (11.9%). CONCLUSION Haemodynamic failure appears as the main determinant of mortality in patients with end-stage heart failure awaiting heart transplantation. ICD seems to have little benefit on survival in this population.


Circulation | 2018

Hypogonadism as a Reversible Cause of Torsades de Pointes in Men

Joe-Elie Salem; Xavier Waintraub; Carine Courtillot; Christian M. Shaffer; Estelle Gandjbakhch; Carole Maupain; Javid Moslehi; Fabio Badilini; Julien Haroche; Paul Gougis; Véronique Fressart; Andrew M. Glazer; Françoise Hidden-Lucet; Philippe Touraine; B. Lebrun-Vignes; Dan M. Roden; Anne Bachelot; Christian Funck-Brentano

Long QT intervals corrected for rate (QTc) >480 to 500 milliseconds predispose to the polymorphic ventricular tachycardia torsades de pointes (TdP).1 Because QTc is shorter and TdP is less frequent in men than in women and because testosterone shortens ventricular repolarization, we examined the effect of hypogonadism and androgen deprivation therapy (ADT) on QTc and TdP risk.2 We prospectively evaluated testosterone and related plasma levels in each man seen with TdP (n=7) over 19 months at a single university hospital (Hopital Pitie-Salpetriere, Paris, France, Commission nationale de l’informatique et des libertes No. 1491960v0, patients’ informed consent obtained). We then analyzed the European pharmacovigilance database (up to June 2017, URL: https://clinicaltrials.gov, Unique identifier: NCT03193138) searching for QTc/TdP adverse drug reactions ( Medical Dictionary for Regulatory Activities terms: long-QT syndrome [LQT], ECG QT-prolonged, and TdP) associated with ADT, and we performed a cross-sectional analysis of the association between the International Classification of Diseases revisions 9 and 10 codes for LQT/TdP and hypogonadism in 1.1 million men in a US electronic health record cohort (up to November 2017, Vanderbilt University Medical Center, Institutional Review Board approval no. 171796).3 Hypogonadism was diagnosed in 7 of 7 cases of TdP (Table). After correction of low testosterone …


Journal of the American Heart Association | 2017

Shortening of the Short Refractory Periods in Short QT Syndrome

Anne Rollin; Estelle Gandjbakhch; Carla Giustetto; Chiara Scrocco; Carole Fourcade; Benjamin Monteil; Pierre Mondoly; Christelle Cardin; Carole Maupain; Fiorenzo Gaita; Philippe Maury

Background Diagnosis of short QT syndrome (SQTS) remains difficult in case of borderline QT values as often found in normal populations. Whether some shortening of refractory periods (RP) may help in differentiating SQTS from normal subjects is unknown. Methods and Results Atrial and right ventricular RP at the apex and right ventricular outflow tract as determined during standard electrophysiological study were compared between 16 SQTS patients (QTc 324±24 ms) and 15 controls with similar clinical characteristics (QTc 417±32 ms). Atrial RP were significantly shorter in SQTS compared with controls at 600‐ and 500‐ms basic cycle lengths. Baseline ventricular RP were significantly shorter in SQTS patients than in controls, both at the apex and right ventricular outflow tract and for any cycle length. Differences remained significant for RP of any subsequent extrastimulus at any cycle length and any pacing site. A cut‐off value of baseline RP <200 ms at the right ventricular outflow tract either at 600‐ or 500‐ms cycle length had a sensitivity of 86% and a specificity of 100% for the diagnosis of SQTS. Conclusions Patients with SQTS have shorter ventricular RP than controls, both at baseline during various cycle lengths and after premature extrastimuli. A cut‐off value of 200 ms at the right ventricular outflow tract during 600‐ and 500‐ms basic cycle length may help in detecting true SQTS from normal subjects with borderline QT values.


Journal of the American College of Cardiology | 2016

ELECTROCARDIOGRAPHY AND ELECTROPHYSIOLOGY STUDIES BEFORE AND AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT AS TOOLS TO DECIDE PERMANENT PACEMAKER IMPLANTATION AND PATIENT'S MONITORING

Caroline Chong-Nguyen; Nicolas Badenco; Carole Maupain; Olivier Barthelemy; Rémi Choussat; Pascal Leprince; Françoise Hidden-Lucet; Robert Frank; Jean-Philippe Collet

Cardiac conduction disturbances frequently occurred after transcatheter aortic valve replacement (TAVR), leading to permanent pacemaker (PPM) implantation. The aim is to identify predictive factors of early and late high degree atrioventricular blocks (AVB). Pacemaker free patients who underwent


Archives of Cardiovascular Diseases Supplements | 2016

0052 : Electrocardiography and electrophysiology studies before and after transcatheter aortic valve replacement as tools to decide permanent pacemaker implantation and patient's monitoring

Caroline Chong-Nguyen; Nicolas Badenco; Carole Maupain; Olivier Barthelemy; R. Choussat; Pascal Leprince; Françoise Hidden-Lucet; Robert Frank; Jean-Philippe Collet

Background Cardiac conduction disturbances frequently occurred after transcatheter aortic valve replacement (TAVR), leading to permanent pacemaker (PPM) implantation. The aim is to identify predictive factors of early and late high degree atrioventricular blocks (AVB). Methods Pacemaker free patients who underwent TAVR from January 2013 to December 2014 were included. His bundle recording (HBR) was performed before TAVR (HV1), immediately after (HV2) and at day 2 for Sapiens valve or day 5 for Medtronic CoreValve (HV3). PPM was implanted if AVB occurred or HV3 > 80ms. Results 84 patients (age 83±9 [mean±SD], Female 59%, Medtroncic Core- Valve 67%) were included. 28 PPM (33%) were implanted for documented AVB (n=17), prolonged HV interval (n=9) or sick sinus syndrome (n=2). High degree AVB after discharge was observed in 13 patients (17.8%). The mean of HV1, HV2 and HV3 were 56ms±10, 71ms ±20 and 63ms ±14, respectively. There was no correlation between HV1, HV2 or HV3 with AVB. Preoperative right bundle branch block (RBBB) and AVB during TAVR were associated with early AVB (respectively p=0.03, p=0.002), leading to prolonged monitoring (fig1). Early post-operative AVB was associated with late AVB (p Conclusions Repeated HBR did not provide any guidance for PPM implantation. RBBB and peroperative high degree AVB are risk factors for AVB after TAVR. Early post-operative AVB is a strong predictive factor of long term recurrence AVB and should be considered for the decision of PPM implantation. Download : Download full-size image Figure . algorithm of patients monitoring before and after TAVR. AVB = atrioventricular block, D=day, TAVR = transcatheter aortic valve replacement The author hereby declares no conflict of interest


Archives of Cardiovascular Diseases Supplements | 2016

0304: How long should we keep a temporary pace maker after transcatheter aortic valve replacement (TAVR)

Robert Frank; Nicolas Badenco; Carole Maupain; Caroline Nguyen; Guillaume Duthoit; Pascal Leprince; Guillaume Lebreton; Olivier Barthelemy; Estelle Gandjbakhch; Jean Philippe Collet

A temporary pace-maker (TPM) is often used after TAVR due to the risk of atrioventricular block (AVB) in the following days, related to progressive conduction system injuries. However guidelines are unclear as when to safely remove it. Between 2013 and 2014, 195 patients without previous permanent pacemaker, were prospectively followed after TAVR (69 Edwards Sapiens (ES) and 126 CoreValve (CV)). 47 had preoperative bundle branch block, 23 left (LBBB), 24 right sided (RBBB). Peri-operative high degree AVB was noted in 37 patients (20%). 24 were transient, less than 10mn and; 13 persisted at the end of the procedure and were implanted with a permanent pace-maker. New LBBB was observed in 55 patients (28%). In the post-operative period, 23 patients (13%) developped AVB (20 patients within 5 days, and 3 patients after 7 days) (4 ES and 19 CV). No new AV block had occurred at one month in the remaining population. Risk factors for late AVB were peri-operative transient AVB (40%), post-operative RBBB (30%), or LBBB (20%); preexistent RBBB and Corevalve model. Conversely 41 of the 42 patients without AVB or bundle branch block did not need temporary pacing in the post operative time. The only patient without any perioperative event who developed a late AV block at day 7 had a CV inserted in an old surgical valve. However, sinus dysfunction occurred in 2 patients treated with amiodarone for atrial fibrillation in the post operative period, needing temporary pacing. Conclusion: The use of TPM after TAVR is common for the management of delayed high degree AVB. The main risk factors are peri-operative AVB and post-operative BBB. Most of delayed AVB occur within 5 days. Later AVB preceded by prolonged PR interval and BBB should increase the length of TPM. However, in the absence of these factors TPM could be shortened. Download : Download high-res image (80KB) Download : Download full-size image Abstract 0304 – Figure: Time occurence of AVB (CV=Corevalve, ES=Sapien)


JACC: Clinical Electrophysiology | 2018

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator

Carole Maupain; Nicolas Badenco; Françoise Pousset; Xavier Waintraub; Guillaume Duthoit; Thomas Chastre; Caroline Himbert; Jean-Louis Hébert; Robert Frank; Françoise Hidden-Lucet; Estelle Gandjbakhch


Archives of Cardiovascular Diseases Supplements | 2016

0281: His bundle recording during and after TAVR to predict early and late atrio-ventricular block

Nicolas Badenco; Caroline Nguyen; Robert Frank; Guillaume Duthoit; Carole Maupain; Françoise Hidden-Lucet; Pascal Leprince; E. Gandjbakhch; Xavier Waintraub; Jean-Philippe Collet

Collaboration


Dive into the Carole Maupain's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pascal Leprince

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xavier Waintraub

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge